−0.030 CAD
−4.71 M CAD
840.53 K CAD
72.37 M
About LOBE SCIENCES LTD.
Sector
CEO
Frederick D. Sancilio
Headquarters
Vancouver
Website
Founded
2010
FIGI
BBG00PD5TC64
Lobe Sciences Ltd. is a biopharmaceutical company, which engages in the discovery and development of transformative medicines to treat rare diseases. It involves in drug research and development using non-hallucinatory doses of stabilized psilocin-based compounds to address unmet medical needs in orphan neurological therapeutic applications. The company was founded on May 13, 2010 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LOBE is 0.020 CAD — it has increased by 33.33% in the past 24 hours. Watch LOBE SCIENCES LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange LOBE SCIENCES LTD. stocks are traded under the ticker LOBE.
LOBE stock has risen by 33.33% compared to the previous week, the month change is a 33.33% rise, over the last year LOBE SCIENCES LTD. has showed a −20.00% decrease.
LOBE reached its all-time high on Jun 19, 2019 with the price of 1.770 CAD, and its all-time low was 0.015 CAD and was reached on Oct 4, 2023. View more price dynamics on LOBE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LOBE stock is 25.00% volatile and has beta coefficient of 0.34. Track LOBE SCIENCES LTD. stock price on the chart and check out the list of the most volatile stocks — is LOBE SCIENCES LTD. there?
Today LOBE SCIENCES LTD. has the market capitalization of 2.57 M, it has increased by 33.33% over the last week.
Yes, you can track LOBE SCIENCES LTD. financials in yearly and quarterly reports right on TradingView.
LOBE net income for the last quarter is −426.80 K CAD, while the quarter before that showed −595.47 K CAD of net income which accounts for 28.33% change. Track more LOBE SCIENCES LTD. financial stats to get the full picture.
No, LOBE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LOBE SCIENCES LTD. EBITDA is −1.68 M CAD, and current EBITDA margin is −394.47%. See more stats in LOBE SCIENCES LTD. financial statements.
Like other stocks, LOBE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LOBE SCIENCES LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LOBE SCIENCES LTD. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LOBE SCIENCES LTD. stock shows the sell signal. See more of LOBE SCIENCES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.